Exploration of Targeted Anti-tumor Therapy

Open Access Systematic Review

Targeting the immune microenvironment in blastic plasmacytoid dendritic cell neoplasm: a genomic perspective

Luigi Cimmino ... Pier Paolo Piccaluga

Published: October 27, 2026 Explor Target Antitumor Ther. 2026;7:1002410

DOI: https://doi.org/10.37349/etat.2026.1002410

Full Text PDF

220 18 0

Open Access Review

Proteoglycans as regulators of cancer biomarker landscapes: implications for precision oncology

Aikaterini Berdiaki ... Dragana Nikitovic

Published: October 27, 2026 Explor Target Antitumor Ther. 2026;7:1002409

DOI: https://doi.org/10.37349/etat.2026.1002409

This article belongs to the special issue Predictive and Prognostic Biomarkers in Cancer: Towards the Precision Medicine Era

Full Text PDF

239 19 0

Open Access Review

Study of the relationship between transposable elements and microRNAs in the development of glioblastoma for its targeted therapy

Rustam Mustafin

Published: October 20, 2026 Explor Target Antitumor Ther. 2026;7:1002408

DOI: https://doi.org/10.37349/etat.2026.1002408

Full Text PDF

268 20 0

Open Access Review

Liquid biopsy in genitourinary cancers: circulating tumor DNA as a predictive biomarker for treatment selection and resistance monitoring

Alcides Chaux, Andrea Paola Britos Gómez

Published: October 19, 2026 Explor Target Antitumor Ther. 2026;7:1002407

DOI: https://doi.org/10.37349/etat.2026.1002407

This article belongs to the special issue Liquid Biopsy: Has Already Changed the Clinical Decision-Making in Solid Tumors Treatment?

Full Text PDF

314 19 0

Open Access Review

Perioperative immune checkpoint inhibition in head and neck squamous cell carcinoma: a 10-year review

Henry Freeman ... Mehrdad Pahlevani

Published: October 19, 2026 Explor Target Antitumor Ther. 2026;7:1002406

DOI: https://doi.org/10.37349/etat.2026.1002406

Full Text PDF

355 13 0

Open Access Review

Wound healing and recurrence in head and neck cancer: a narrative review

Micah K. Harris ... Matthew E. Spector

Published: October 15, 2026 Explor Target Antitumor Ther. 2026;7:1002405

DOI: https://doi.org/10.37349/etat.2026.1002405

Full Text PDF

312 10 0

Open Access Review

Redefining axillary management by selecting patients for omission of sentinel lymph node surgery in early breast cancer

Wiebren Tjalma, Seppe Coenen

Published: October 09, 2026 Explor Target Antitumor Ther. 2026;7:1002404

DOI: https://doi.org/10.37349/etat.2026.1002404

This article belongs to the special issue Breaking Boundaries in Breast Cancer Care: Emerging Controversies and Innovation in Surgical and Medical Approaches

Full Text PDF

367 17 0

Open Access Meta-Analysis

Addition of immune checkpoint inhibitor to standard of care chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma: a systematic review and meta-analysis

Ramaditya Srinivasmurthy ... Kyaw Zin Thein

Published: September 28, 2026 Explor Target Antitumor Ther. 2026;7:1002403

DOI: https://doi.org/10.37349/etat.2026.1002403

Full Text PDF

752 25 0

Open Access Original Article

Significance of next-generation sequencing in the era of targeted therapy for biliary tract cancer: an analysis at a single institution

Kei Nakagawa ... Michiaki Unno

Published: September 18, 2026 Explor Target Antitumor Ther. 2026;7:1002402

DOI: https://doi.org/10.37349/etat.2026.1002402

This article belongs to the special issue Targeted and Precision Therapy for Adult Hepatopancreatobiliary Cancers and Liver Metastases

Full Text PDF

606 21 0

Open Access Review

Cardiotoxicity in breast cancer patients treated with chemoradiotherapy

Peter Emerson, Liza Thomas

Published: September 14, 2026 Explor Target Antitumor Ther. 2026;7:1002401

DOI: https://doi.org/10.37349/etat.2026.1002401

This article belongs to the special issue Breaking Boundaries in Breast Cancer Care: Emerging Controversies and Innovation in Surgical and Medical Approaches

Full Text PDF

714 17 0

Open Access Review

Post-CDK4/6 inhibitor therapy in HR+/HER2– advanced breast cancer: expanding options and persisting uncertainties

Anne-Murielle Hollinger, Ruben Bill

Published: September 11, 2026 Explor Target Antitumor Ther. 2026;7:1002400

DOI: https://doi.org/10.37349/etat.2026.1002400

This article belongs to the special issue Breaking Boundaries in Breast Cancer Care: Emerging Controversies and Innovation in Surgical and Medical Approaches

Full Text PDF

1653 38 0

Open Access Perspective

Mitochondrial checkpoint for interferon responses in macrophages

Andreas O. Mieland, Oliver H. Krämer

Published: August 19, 2026 Explor Target Antitumor Ther. 2026;7:1002399

DOI: https://doi.org/10.37349/etat.2026.1002399

Full Text PDF

911 28 0

Open Access Review

Response-adaptive breast cancer care in the grey zones: integrating ER and HER2 targeted PET, FDG PET/CT under immunotherapy, and ctDNA kinetics

Jovana Zivanovic, Jules Zhang-Yin

Published: August 16, 2026 Explor Target Antitumor Ther. 2026;7:1002398

DOI: https://doi.org/10.37349/etat.2026.1002398

This article belongs to the special issue Breaking Boundaries in Breast Cancer Care: Emerging Controversies and Innovation in Surgical and Medical Approaches

Full Text PDF

1277 36 0

Open Access Review

Bioethical challenges in the implementation of targeted anti-tumor therapies in low-resource settings: a perspective from Latin America

Alcides Chaux

Published: August 10, 2026 Explor Target Antitumor Ther. 2026;7:1002397

DOI: https://doi.org/10.37349/etat.2026.1002397

Full Text PDF

992 31 1

Open Access Review

Precision oncology in the treatment of patients with bone sarcomas: an up-to-date narrative review

Sude Yarar, Panagiotis Tsagkozis

Published: August 09, 2026 Explor Target Antitumor Ther. 2026;7:1002396

DOI: https://doi.org/10.37349/etat.2026.1002396

This article belongs to the special issue Precision Oncology: Molecular Classification, Efficacy Prediction, and Treatment Decision-Making

Full Text PDF

1274 25 0

Open Access Original Article

Safety and efficacy of delivering systemic treatments concomitantly with whole-brain radiotherapy: a prospective, observational, single-institution study

Maria Protopapa ... Anna Zygogianni

Published: August 07, 2026 Explor Target Antitumor Ther. 2026;7:1002395

DOI: https://doi.org/10.37349/etat.2026.1002395

Full Text PDF

838 12 0

Open Access Review

Liquid biopsy in breast cancer: current biomarker platforms and clinical applications

Pritam Saha Podder ... Stefano Cinti

Published: August 05, 2026 Explor Target Antitumor Ther. 2026;7:1002394

DOI: https://doi.org/10.37349/etat.2026.1002394

This article belongs to the special issue Breaking Boundaries in Breast Cancer Care: Emerging Controversies and Innovation in Surgical and Medical Approaches

Full Text PDF

1721 34 1

Open Access Original Article

Dendritic cell-based immunotherapy modulates the systemic inflammatory profile in a 4T1 breast cancer model

Tauana Christina Dias ... Márcia Antoniazi Michelin

Published: August 05, 2026 Explor Target Antitumor Ther. 2026;7:1002393

DOI: https://doi.org/10.37349/etat.2026.1002393

Full Text PDF

991 17 0

Open Access Original Article

Consensus statements on the definition, diagnosis, and management of oligoprogressive disease: results of an expert survey of Kazakhstan Cancer Society

Dilyara Kaidarova ... Timur Mitin

Published: August 05, 2026 Explor Target Antitumor Ther. 2026;7:1002392

DOI: https://doi.org/10.37349/etat.2026.1002392

Full Text PDF

6034 31 1

Open Access Original Article

Transcriptional modulation of the PI3K/AKT/mTOR signaling pathway mediated by HPV16 E5, E6, and E7 oncogene expression in breast cancer

Beatriz Eda de Oliveira Isídio ... Antonio Carlos de Freitas

Published: August 04, 2026 Explor Target Antitumor Ther. 2026;7:1002391

DOI: https://doi.org/10.37349/etat.2026.1002391

This article belongs to the special issue Breaking Boundaries in Breast Cancer Care: Emerging Controversies and Innovation in Surgical and Medical Approaches

Full Text PDF

1333 14 2